Two out of every three women diagnosed with high-risk early breast cancer can safely skip chemotherapy after surgery, ...

A new study by investigators from Mass General Brigham Cancer Institute found that an ultrasensitive blood test called ...

Thousands of cancer patients have untapped treatment options in their genomic data. Now they can find them. Available in 12 ...

Many repetitive regions of the genome have been considered "junk DNA" because the available technologies did not allow them ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

Experts discuss Prosigna-guided treatment decisions in high-risk early disease ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid May 27 (Reuters) - Today we feature studies to be presented at ...

Scientists reflect on the breakthroughs and collaborative efforts that shaped The Cancer Genome Atlas (TCGA)’s legacy.

Many repetitive regions of the genome have been considered "junk DNA" because the technologies available did not allow them to be studied at sufficient resolution.

In this blog, Kirsty Irvine, Chair of the Participant Panel at Genomics England, discusses the importance of involving the ...